Skip to main content

ZYNEX INC (ZYXI) Stock Forecast 2025 - AI Price Prediction & Analysis


ZYNEX INC (ZYXI) AI Stock Price Forecast & Investment Analysis

ZYNEX INC Stock Price Chart and Technical Analysis

Loading ZYNEX INC interactive price chart and technical analysis...

ZYNEX INC (ZYXI) - Comprehensive Stock Analysis & Investment Research

Deep dive into ZYNEX INC's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about ZYNEX INC, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For ZYNEX INC: ZYNEX INC operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

ZYNEX INC (Stock Symbol: ZYXI) is a leading company in the Industrial Applications and Services sector , specifically operating within the Electromedical & Electrotherapeutic Apparatus industry.

The organization employs approximately 891 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing ZYNEX INC's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For ZYNEX INC: With $144M in annual revenue and 2.5% net margin, the company demonstrates developing profitability.

Annual Revenue: $144 million generating a 2.5% net profit margin .

Market Capitalization: $46 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 29.1% - Exceptional shareholder return efficiency, indicating strong management effectiveness.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for ZYNEX INC stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For ZYNEX INC: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for ZYNEX INC stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: ZYNEX INC's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For ZYNEX INC: Strong free cash flow generation demonstrates developing operational efficiency.

ZYNEX INC strategically competes in the highly dynamic Electromedical & Electrotherapeutic Apparatus marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $14 million annually, complemented by impressive -87.0% year-over-year cash flow growth.

The company maintains a healthy 1.1% gross margin, indicating strong pricing power and operational efficiency.

ZYNEX INC (ZYXI) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for ZYNEX INC stock analysis.

Loading ZYNEX INC comprehensive fundamental analysis and insider trading data...

Deep dive into ZYNEX INC's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if ZYNEX INC stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For ZYNEX INC: With a P/E ratio of 41.41, the market highly values future growth prospects.

P/E Ratio 41.41x
P/B Ratio 36.54x
Market Cap $46M
Dividend Yield 1.12%
EPS $-0.93
Book Value/Share $0.04
Revenue/Share $4.68
FCF/Share $0.11
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently ZYNEX INC converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For ZYNEX INC: An ROE of 29.1% demonstrates excellent shareholder value creation.

ROE 29.1%
ROA 19.0%
ROIC 22.5%
Gross Margin 1.1%
Operating Margin 4.6%
Net Margin 2.5%
EBT Margin 18.5%
Tax Rate 24.3%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess ZYNEX INC's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For ZYNEX INC: A current ratio of 3.67 indicates strong liquidity.

Current Ratio 3.67x
Quick Ratio 3.00x
D/E Ratio 0.32x
Financial Leverage 1.74x
Interest Coverage 121.7x
Working Capital $53M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal ZYNEX INC's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For ZYNEX INC: Free cash flow of $14M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $14M
Free Cash Flow $14M
OCF Growth YoY -87.0%
FCF Growth YoY -26.2%
FCF/Sales 9.9%
CapEx/Sales 0.3%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively ZYNEX INC uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For ZYNEX INC: An asset turnover of 1.36x demonstrates efficient asset utilization.

Asset Turnover 1.36x
Receivables Turnover 6.4x
Inventory Turnover 2.3x
Fixed Assets Turnover 10.8x
Days Sales Outstanding 57 days
Days Inventory 157 days
Payables Period 64 days
Cash Conversion Cycle 151 days
Understanding Financial Statement Data

What these metrics mean: Key figures from ZYNEX INC's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For ZYNEX INC: With annual revenue of $144M, ZYNEX INC demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $144M
SG&A Expense $61M
Cost of Goods Sold $40M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 62%
Cash & Short-term Investments 30%
Total Liabilities 43%
Short-term Debt 4%
Accounts Receivable 21%
Inventory 10%
Dividend & Shareholder Information
Dividends Per Share $0.15
Shares Outstanding 31M
Growth Metrics (YoY)
EPS Growth 1.9%

Latest ZYNEX INC Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting ZYNEX INC (ZYXI) stock price and investment outlook.

ZYNEX INC Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of ZYNEX INC against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AXGN Unlock Forecast - 30 Days FREE Trial $751M -41.7x 6.7x
BLFS Unlock Forecast - 30 Days FREE Trial $991M -14.7x 2.8x
BSGM Unlock Forecast - 30 Days FREE Trial $126M -1.8x 48.5x
CBLL Unlock Forecast - 30 Days FREE Trial $438M x 2.5x
CNMD Unlock Forecast - 30 Days FREE Trial $1676M 15.2x 1.7x
CUTR Unlock Forecast - 30 Days FREE Trial $9M -0.1x 0.0x
CV Unlock Forecast - 30 Days FREE Trial $0M x x
ECOR Unlock Forecast - 30 Days FREE Trial $37M -7.3x 32.8x
EDAP Unlock Forecast - 30 Days FREE Trial $99M x 2.4x
ELMD Unlock Forecast - 30 Days FREE Trial $218M 28.9x 5.1x
FONR Unlock Forecast - 30 Days FREE Trial $99M 9.5x 0.6x
GTHP Unlock Forecast - 30 Days FREE Trial $22M x x
HSDT Unlock Forecast - 30 Days FREE Trial $66M 0.0x 51.9x
HYPR Unlock Forecast - 30 Days FREE Trial $148M -1.8x 0.9x
INMD Unlock Forecast - 30 Days FREE Trial $1207M x 1.7x
IRIX Unlock Forecast - 30 Days FREE Trial $24M -2.8x 3.9x
IRME Unlock Forecast - 30 Days FREE Trial $1M x x
ITGR Unlock Forecast - 30 Days FREE Trial $3800M 46.0x 2.2x
LIVN Unlock Forecast - 30 Days FREE Trial $3199M -662.0x 2.9x
MASI Unlock Forecast - 30 Days FREE Trial $8132M 128.1x 7.8x
MDT Unlock Forecast - 30 Days FREE Trial $121684M 26.1x 2.5x
MOVE Unlock Forecast - 30 Days FREE Trial $5M -8.6x 0.7x
NDRA Unlock Forecast - 30 Days FREE Trial $2M -0.8x 1.1x
NRXS Unlock Forecast - 30 Days FREE Trial $24M -0.9x 5.6x
NUWE Unlock Forecast - 30 Days FREE Trial $65M -0.1x 18.1x
NXL Unlock Forecast - 30 Days FREE Trial $15M -4.7x 2.4x
NXLIW Unlock Forecast - 30 Days FREE Trial $5M x 1.0x
OM Unlock Forecast - 30 Days FREE Trial $249M -0.4x 1.6x
POCI Unlock Forecast - 30 Days FREE Trial $36M -11.5x 2.8x
QTI Unlock Forecast - 30 Days FREE Trial $7M -0.4x -0.8x
SLNO Unlock Forecast - 30 Days FREE Trial $4417M -18.5x 19.0x
SMLR Unlock Forecast - 30 Days FREE Trial $385M 10.4x 1.0x
STRR Unlock Forecast - 30 Days FREE Trial $7M -1.6x 0.1x
STRRP Unlock Forecast - 30 Days FREE Trial $31M -5.5x 0.5x
STXS Unlock Forecast - 30 Days FREE Trial $1182M -8.4x 811.5x
TIVC Unlock Forecast - 30 Days FREE Trial $3M 0.0x 0.8x
TMDX Unlock Forecast - 30 Days FREE Trial $4357M 60.8x 13.7x
VANI Unlock Forecast - 30 Days FREE Trial $92M -2.7x 7.9x
VASO Unlock Forecast - 30 Days FREE Trial $21M 20.1x 0.8x
ZYXI Unlock Forecast - 30 Days FREE Trial $46M 41.4x 36.5x

Frequently Asked Questions - ZYNEX INC Stock Forecast

How accurate are ZYNEX INC stock predictions?

Our AI model demonstrates 48% historical accuracy for ZYXI predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence ZYNEX INC stock price forecasts?

Our analysis considers ZYNEX INC's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is ZYNEX INC a good investment in 2025?

Based on our AI analysis, ZYNEX INC shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are ZYNEX INC forecasts updated?

ZYNEX INC stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced ZYNEX INC Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for ZYNEX INC stock.

My Portfolio

Investment Dashboard

Loading your portfolio...